Clinical Trial Update: Rituximab to the Preparative Regimen of Etoposide and Total Body Irradiation in Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated adding Rituximab to a preparative regimen of etoposide and total body irradiation in acute lymphoblastic leukemia; results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Etoposide (Etoposide)
• Rituxan (rituximab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2012-05-07